Fulhold Pharma Plc produces the patented CarboHydrate Derived Fulvic Acid (CHD-FA) and formulations containing this product. CHD-FA and its use provides a new pharmaceutical platform technology with wide applications in human and animal health. We produce CHD-FA using a sustainable, environmentally-friendly technology, the process of which is also patented.
View Top Employees from Fulhold Pharma Plc| Website | http://www.fulholdpharma.com |
| Revenue | $5 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2002 |
| Technologies |
JavaScript,
HTML,
PHP
+4 more
(view full list)
|
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Fulhold Pharma Plc employee's phone or email?
Fulhold Pharma Plc Questions
The Fulhold Pharma Plc annual revenue was $5 million in 2023.
Stewart Clark is the Chief Scientific Officer of Fulhold Pharma Plc.
1 people are employed at Fulhold Pharma Plc.
Fulhold Pharma Plc is based in Stellenbosch, Western Cape.
The NAICS codes for Fulhold Pharma Plc are [325, 3254, 32541, 32].
The SIC codes for Fulhold Pharma Plc are [28, 283].
Top Fulhold Pharma Plc Employees
